Clonidine is a specific \g=a\-2-adrenoreceptoragonist that stimulates growth hormone (GH) release in animals and humans. This drug was used to study the GH and prolactin (PRL) secretory response in dairy cows and heifers. An i.v. infusion of 10 \g=m\g/kgbody weight induced GH release to a peak concentration after 30\p=n-\60min, while 2 \g=m\g/kg had no effect on GH secretory patterns. Plasma PRL decreased significantly (P<0\m=.\01)starting 15\p=n-\60min after both doses of clonidine, this effect lasting up to 6 h. Clonidine significantly lowered plasma insulin (P<0\m=.\01) and raised plasma glucose (P<0\m=.\01). The changes in plasma GH, PRL, insulin and glucose differed significantly between doses, the 10 \g=m\g/kg dose being more effective (P<0\m=.\01). The results of our investigation in dairy cattle provide evidence of (i) an increase in GH release after 10 \g=m\g/kgclonidine; (ii) a concomitant decrease in PRL secretion, hence GH and PRL secretion in cattle appear inversely controlled; (iii) a significant difference between the effects of the 2 and 10 \g=m\g/kg doses and (iv) no relationship between the changes in plasma GH and PRL after clonidine and plasma hormone levels before treatment.
Introduction
Much knowledge has been gained in the past few years as to how neuroactive drugs influence brain neurotransmitter synthesis or action. Clonidine, a member of this class, is a specific -2-adrenoreceptor agonist that elicits growth hormone (GH) release in the rat (Durand et al. 1977 , Siever et al. 1987 , cat, dog, monkey (Muller 1987) , sheep (Thomas et al. 1994 ) and man (Lai et al. 1975) through stimulation of endogenous GH-releasing hormone (Müller 1987 ).
Clonidine appears not to be involved in the regulation of prolactin (PRL) secretion in man and rat, or of adreno¬ corticotropic hormone, follicle-stimulating hormone, luteinizing hormone or thyroid-stimulating hormone secretion (Lai et al. 1975 ). It does, however, appear to induce a rapid and significant reduction in serum PRL levels in non-human primates (Gold et al. 1978) . In heifers, clonidine elicits a significant GH secretory burst at doses ranging from 5 to 30 pg/kg body weight (Gorewit 1981 , Kuehner et al. 1993 ) while pituitary PRL secretion was not affected by 20 pg/kg but was acutely stimulated by 2 pg/kg (Gorewit 1981) . These findings imply a dose-dependent -2-adrenergic secretory dependence for bovine PRL. In man, studies with apomorphine, a selec¬ tive dopamine receptor agonist, suggest an inverse dopa¬ minergic system control of GH and PRL secretion, and central -adrenergic clonidine stimulation has been confirmed (Lai et al. 1973 ).
The present study, therefore, investigated the pituitary response to clonidine in dairy cattle. The specific objective was to analyse the plasma GH (Secchi et al. 1988 (Secchi et al. , 1991 . The sensitivity was 0-25 ng/ml for bGH and 0T ng/ml for bPRL. The intraand inter-assay coefficients of variation ranged between 2-6-51% and 8-3-12-1% respectively for bGH, and 3-0-71% and 6-0-14-5% respectively for bPRL. Plasma insulin concentrations were determined by double-antibody radioimmunoassay. r=5-93; P<0-01). Computer analyses were carried out using the Gauss program, version 2-2 (Aptech Systems Inc., Kent, WA, USA).
Results

Plasma bGH
The bGH secretory patterns of groups I, II and III are shown in Fig. 1 (means±s.e.m.) . Cows in group I showed a highly significant difference in plasma bGH after 10 pg/kg clonidine ( <0 1). Analysis of pre-treatment and post-control treatment periods for the three groups showed that blood sam¬ pling and saline infusion had no effect on plasma PRL concentrations (P>0-1).
Plasma insulin
The insulin secretory patterns of the three groups are shown in Fig. 3 (means ± s.e.m.). Clonidine lowered insulin within 15 min after injection in all three groups ( <0 1). Plasma insuhn remained low for at least 3 h after the 10 pg/kg dose (99% confidence limits: ± 8-57) and 2 h after the 2 pg/kg dose (99% confidence limits, group II ± 9-85; group III ± 8-53); during these periods the plasma concentrations remained significantly below the control value ( <0·01).
Neither blood samphng nor sahne infusion influenced hormonal plasma concentrations (P>0T). Clonidine at 10 pg/kg had a significandy greater effect on plasma insulin than 2 pg/kg (t=3-45; <0 1).
Plasma glucose Fig. 4 shows the plasma glucose patterns of the three groups (means±s.e.m.). Clonidine significantly raised plasma glucose in all groups (P<0-01), while blood sampling and sahne infusion had no effect (P>0T).
The hyperglycemia started at 15 min and peaked 60-180 min after treatment. The animals given 10 pg/kg clonidine still had high plasma glucose after 6 h, by which time all the animals given 2 pg/kg had normal concen¬ trations (99% confidence limits: group I ±398; group II ±9-75; group III ±8-48). During these times plasma glucose was significantly higher than the control value (P-C0-01).
In cows there was a significant difference between doses of clonidine ( =5·29; <0 1), the effect being more pronounced after 10 pg/kg. Discussion GH and PRL are similar hormones synthesised and secreted by two acidophil cell types of the adenohypophy¬ sis (Nilson et al. 1983 (Kazmer et al. 1986 , Secchi et al. 1988 , and it has been suggested that elevated GH concentrations might depend on the genetic selection for milk yield (Kazmer et al. 1986 , Lovendahl et al. 1991 , Woolliams et al 1993 .
Basal levels of bPRL in the bovine are similar for animals in the same season. However concentrations rise signifi¬ cantly during the period May-Aug as previously described for bovine and other species (Curlewis 1992 , Borromeo et al. 1994 ); this explains the difference between the bPRL plasma concentrations of animals subjected to experiments in June or September.
The nine cows given 10 pg/kg bw responded to clonidine with a GH secretory burst smaller than that reported by Kuehner et al. (1993) who found peak values were ten times the basal levels. The present data are more consistent with the findings described by Gorewit (1981) , although both these studies used 10-month-old heifers.
In the same study, Gorewit (1981) In our study clonidine lowered plasma insulin and raised plasma glucose in heifers and cows. The percentage increases in plasma glucose after 10 and 2 pg/kg clonidine were greater than in humans (Lai et al. 1975 , Hunt et al. 1986 ). Although the increase in plasma glucose may be largely due to the fall in insulin levels reported in this study, other mechanisms of action of clonidine should also be considered. We report that clonidine, at 10 pg/kg, increases plasma GH. As GH at high doses has been shown to induce hyperglycemia in the bovine (Bourne et al. 1977) , a contribution by this hormone to the increased blood glucose levels may be possible. However 2 pg/kg clonidine also causes hyperglycaemia, although there is no stimulation of GH release. Other possible modes of action of clonidine include a direct stimulatory effect on the hver via -2-adrenergic receptors (Gorewit 1980) to increase glucose output, glycogenolysis and inhibit glucose uptake. At the same time clonidine may exert this effect centrally via activation of the sympathetic nervous system (Goodman & Gilman 1990) . Similar direct or indirect effects of clonidine occur at the level of the pancreas to inhibit insuhn release (Metz et al. 1978 ).
In conclusion, this is the first report of an inverse control of GH and PBT secretion in clonidine-stimulated dairy cattle. The data indicate that the bPRL secretory mech¬ anism is more sensitive to clonidine action than bGH, and suggest that the bovine species could be a new experimental model for the studies described above.
